Skip to main content
. Author manuscript; available in PMC: 2020 Sep 16.
Published in final edited form as: J Neurooncol. 2019 Jul 19;144(2):403–407. doi: 10.1007/s11060-019-03243-7

Table 3:

Grade 1 and 2 toxicities

Toxicity N %
Elevated alanine aminotransferase (ALT) 12 40
Hyperglycemia 12 40
Fatigue 10 33
Thrombocytopenia 9 30
Diarrhea 7 23
Elevated aspartate transaminase (AST) 6 20
Hypophosphatemia 5 17
Leukopenia 5 17
Nausea 5 17
Alkaline Phosphatase 3 10
Hyperkalemia 2 7
Vomiting 2 7
Dysgeusia 1 3
Hypernatremia 1 3
Hypertriglyceridemia 1 3
Lymphopenia 1 3

Adverse events possibly, probably, or definitely attributed to perifosine, per patient (n=30)